Legislative Comment
- Vascular Access
- Uncategorized
- Training
- Storytelling
- Sponsored
- Scheduling
- Risk Management
- Regulatory Comment
- Providers
- Press Release
- Pharmacology
- Patients
- Operations
- Legislative Comment
- Legal Risk Mitigation
- Legal
- Insurance
- Infusion Patients
- In The News
- Emergency Resources
- Disease Management
- Data Management
- Chronic Illness
- Billing
- Artificial Intelligence
- Advocacy
- Access Issues
 In October 2026, NICA submitted comments to the Senate Finance Committee on addressing insurance practices that create barriers to necessary medical care. NICA highlighted several policies that […]
In August 2026, NICA submitted comments to Senator Bill Cassidy, MD (R-La.) regarding his discussion draft of the 340B Drug Pricing Integrity and Affordability for Patients […]
In August 2026, NICA submitted comments to the House Republican and Democratic Doctors Caucuses on ways to strengthen Medicare’s physician payment system. NICA emphasized that more stable […]
In August 2026, NICA submitted comments to the Senate Finance Committee on proposals to lower prescription drug costs. NICA highlighted several policies that can affect what […]
In February 2026, NICA sent a letter to the Senate Health, Education, Labor, and Pensions (HELP) Committee expressing concerns about proposed Most Favored Nation (MFN) drug […]
In January 2026, NICA urged congressional leadership to advance pharmacy benefit manager (PBM) reform provisions included in the Consolidated Appropriations Act of 2026. NICA highlighted concerns […]
In January 2026, NICA provided feedback to Representatives Greg Murphy and Kim Schrier on modernizing the Medicare Access and CHIP Reauthorization Act (MACRA). NICA advocated for […]